Clinical Trials

Below is a list of active clinical trials worldwide which involve patients with inherited bleeding disorders. The link from each study title will take you to ClinicalTrials.gov which gives you more information about the trial.
To see a list of trials for a particular bleeding disorder use the drop-down list below to select the condition you're interested in. A new window will open up with a list of trials for this condition only.

TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies Conditions: Hemophilia A; Factor VIII (FVIII) Interventions: Drug: Half-life factor VIII based replacement therapy; Drug: Non-FVIII based replacement therapy Sponsors: University of Texas Southwestern Medical Center; Sanofi Not yet recruiting

High-Flow Nasal Cannula Versus Nasal CPAP as Primary Support in Preterm Respiratory Distress Syndrome Conditions: Premature Birth; Respiratory Distress Syndrome, Newborn Interventions: Device: Group 1 Heated humidified high-flow nasal cannula (HHHFNC); Device: Group 2 Nasal continuous positive airway pressure (nCPAP) Sponsors: Kayseri City Hospital Completed

Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia Patients Conditions: Hemophilia A and B; Periodontitis; Hemophilia Interventions: Procedure: Non-surgical periodontal treatment Sponsors: Karadeniz Technical University Completed

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment. Conditions: Severe Hemophilia A Interventions: Drug: FRSW107 Sponsors: Hangzhou Gensciences Biopharmaceutical Co., Ltd. Recruiting

Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain Conditions: Hemophilia; Chronic Pain Interventions: Behavioral: other; Other: Exercise Sponsors: University of Chile Recruiting

LATE-ONSET POMPE DISEASE AND CEREBROVASCULAR MANIFESTATIONS Conditions: Late-Onset Pompe Disease Sponsors: Hospitales Universitarios Virgen del Rocío; Sanofi Completed

A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia Conditions: Liver Cirrhosis Interventions: Drug: Foscenvivint Sponsors: Kiminori Kimura, MD; Japan Agency for Medical Research and Development; Ohara Pharmaceutical Co., Ltd. Not yet recruiting